Nuromol is intended to be used only after a person has tried either ibuprofen or paracetamol alone for the first day of treatment. Undesirable effects such as dizziness, drowsiness, fatigue and visual disturbances are possible after taking NSAIDs. If you are allergic to paracetamol, ibuprofen, aspirin or other anti-inflammatory medicines or medicines for pain relief.

Acute generalised exanthematous pustulosis (AGEP) has been reported in relation to ibuprofen-containing products.When GI bleeding or ulceration occurs in patients receiving ibuprofen containing products, the treatment should be withdrawn. When you want even more softness, Kleenex ultra soft tissues are there for you with a little extra TLC. If you do require precise ingredient information you should consult the manufacturer, whose contact details will appear on the packaging or label. Considering the intake of paracetamol alone, when using Nuromol, the maximum daily dose is 1g less than that of single ingredient paracetamol products licensed for the treatment of pain and classified as GSL. In patients with active, or a history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulceration or bleeding).

ATC Code: M01AE51 – Musculoskeletal system, anti-inflammatory and antirheumatic products, non-steroids, propionic acid derivatives. In severe poisoning, hepatic failure may progress to encephalopathy, haemorrhage, hypoglycaemia, cerebral oedema and death. Are allergic to ibuprofen, paracetamol or any other ingredient of the product, aspirin or other related painkillers.signs of a severe allergic reaction (swelling of the face, tongue, or throat, difficulty breathing, worsening of asthma). Immediate medical advice should be sought if this occurs, even if you feel well as this can result in an overdose (see section 4. Appropriate monitoring and medical advice are required for patients with a history of hypertension and/or mild to moderate congestive heart failure as fluid retention, hypertension and oedema have been reported in association with NSAID therapy. In relation to the paracetamol content of the product, the concerns about paracetamol toxicity apply to all solid dose oral paracetamol products including those already available as GSL.